Light Adjustable Intraocular Lens (LAL ) for Post-Cataract Surgery Power Adjustments

This contract pertains to the procurement of the Light Adjustable Intraocular Lens (LAL) specifically designed for use during cataract surgery, with the unique capability of allowing lens power adjustments post-operatively within the eye. The contract is awarded to RxSight through a sole source procurement process, justified by the proprietary nature of the product, which is the only intraocular lens that can be adjusted after implantation. The purchase is managed by the University of New Mexico Health Sciences Center, with a contract value estimated at around $100,000 for an initial three-year term, including potential renewals. The procurement process involved thorough due diligence, confirming that no other vendors offer comparable adjustable lenses, and was finalized with official approval in late October 2025. The contract emphasizes the innovative features of the Light Adjustable Lens, which enhances post-surgical visual outcomes by enabling precise adjustments after cataract surgery, a capability not available with traditional intraocular lenses. The documentation highlights the proprietary status of the product, the justification for sole sourcing, and the strategic importance of acquiring this advanced technology for the university’s ophthalmology services. The primary point of contact for the contract is NJ Adams from the Department of Ophthalmology, with communication facilitated via email and phone. The procurement process underscores the commitment to leveraging cutting-edge medical technology to improve patient care in ophthalmic procedures.